Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) EBT Margin (2020 - 2025)

Celularity (CELU) has disclosed EBT Margin for 6 consecutive years, with 593.54% as the latest value for Q4 2025.

  • For Q4 2025, EBT Margin rose 133858.0% year-over-year to 593.54%; the TTM value through Dec 2025 reached 345.44%, down 18802.0%, while the annual FY2025 figure was 345.44%, 23866.0% down from the prior year.
  • EBT Margin hit 593.54% in Q4 2025 for Celularity, down from 436.71% in the prior quarter.
  • Across five years, EBT Margin topped out at 1267.03% in Q2 2022 and bottomed at 3065.38% in Q1 2021.
  • Average EBT Margin over 5 years is 668.92%, with a median of 300.36% recorded in 2024.
  • Year-over-year, EBT Margin skyrocketed 328383bps in 2022 and then crashed -289906bps in 2023.
  • Celularity's EBT Margin stood at 82.78% in 2021, then soared by 815bps to 592.08% in 2022, then tumbled by -87bps to 78.91% in 2023, then tumbled by -2549bps to 1932.12% in 2024, then surged by 69bps to 593.54% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 593.54%, 436.71%, and 427.55% for Q4 2025, Q3 2025, and Q2 2025 respectively.